XORTX Therapeutics (XRTX) Invested Capital (2020 - 2021)
XORTX Therapeutics (XRTX) posted Invested Capital of $556127.8 for Q4 2021, down 29.9% on a QoQ basis from $793297.9 in Q4 2020, and down 29.9% year-over-year from $793297.9 in Q4 2020.
XORTX Therapeutics (XRTX) Invested Capital (2020 - 2021) Analysis & Trends
XORTX Therapeutics' Invested Capital history runs 2 years deep, the most recent figure standing at $556127.8 for Q4 2021.
- Quarterly Invested Capital fell 29.9% year-over-year to $556127.8 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $556127.8 (down 29.9% YoY) and the FY2021 annual result came in at $559366.0, down 27.55% from the prior year.
- Invested Capital was $556127.8 for Q4 2021 at XORTX Therapeutics, down from $793297.9 in the prior quarter.
- Across five years, Invested Capital topped out at $793297.9 in Q4 2020 and bottomed at $556127.8 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | 110.96 Mn |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn | 116.14 Mn |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | - |
| 10 | XORTX Therapeutics | 2.80 Bn | 2.80 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 556,127.80 |
| Dec 31, 2020 | 793,297.91 |